GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (TSX:RVX) » Definitions » Equity-to-Asset

Resverlogix (TSX:RVX) Equity-to-Asset : -9.82 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Resverlogix's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$-98.94 Mil. Resverlogix's Total Assets for the quarter that ended in Mar. 2024 was C$10.08 Mil.

The historical rank and industry rank for Resverlogix's Equity-to-Asset or its related term are showing as below:

TSX:RVX' s Equity-to-Asset Range Over the Past 10 Years
Min: -20.89   Med: -6.17   Max: -0.64
Current: -9.82

During the past 13 years, the highest Equity to Asset Ratio of Resverlogix was -0.64. The lowest was -20.89. And the median was -6.17.

TSX:RVX's Equity-to-Asset is ranked worse than
97.68% of 1555 companies
in the Biotechnology industry
Industry Median: 0.67 vs TSX:RVX: -9.82

Resverlogix Equity-to-Asset Historical Data

The historical data trend for Resverlogix's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Equity-to-Asset Chart

Resverlogix Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.75 -5.64 -6.00 -7.31 -11.42

Resverlogix Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -8.52 -9.14 -11.42 -9.82

Competitive Comparison of Resverlogix's Equity-to-Asset

For the Biotechnology subindustry, Resverlogix's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Resverlogix's Equity-to-Asset falls into.



Resverlogix Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Resverlogix's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-99.914/8.746
=

Resverlogix's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=-98.937/10.079
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resverlogix  (TSX:RVX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Resverlogix Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Resverlogix's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix (TSX:RVX) Business Description

Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Executives
Aaron Bradley Cann Senior Officer

Resverlogix (TSX:RVX) Headlines

No Headlines